Medical Services Expenditures per Capita by Disease: Endocrine; Nutritional; and Metabolic Diseases and Immunity Disorders, MEPS Account Basis (EDCNMIPCMEPS) | FRED | St. Louis Fed
- Rows
- 22
- Columns
- 2
- Data range
- 2000-01-01 to 2021-01-01
Graph and download economic data for Medical Services Expenditures per Capita by Disease: Endocrine; Nutritional; and Metabolic Diseases and Immunity Disorders, MEPS Account Basis (EDCNMIPCMEPS) from 2000 to 2021 about disease, healthcare, nutrition, medical, health, expenditures, per capita, services, and USA.
AI analysis
Analysis: Medical Services Expenditures per Capita — Endocrine/Nutritional/Metabolic/Immunity Disorders (EDCNMIPCMEPS)
1. Dataset Overview and Value
This dataset, sourced from the St. Louis Fed's FRED API (fredgraph.csv?id=EDCNMIPCMEPS), tracks annual per-capita medical services expenditures for endocrine, nutritional, metabolic, and immunity-related diseases in the USA, spanning 2000–2021. As a FRED-published series, it inherits FRED's reputation for curated, revision-tracked macroeconomic and health-economic data, drawing from the Medical Expenditure Panel Survey (MEPS) — a well-regarded federal survey administered by AHRQ. Given this disease category encompasses diabetes, thyroid disorders, obesity-related metabolic conditions, and autoimmune diseases, this series is highly valuable for correlation studies linking healthcare cost trends to obesity/diabetes prevalence rates, insurance coverage changes, pharmaceutical pricing (e.g., insulin costs), and broader inflation or CPI-medical-care indices over the same two-decade window.
2. Data Quality Observations
The dataset is exceptionally clean at face value: zero null cells across both columns, and all 22 rows have complete date and value entries (distinct=22 for both, confirming no duplicate observation dates or repeated values suggesting a placeholder/fill issue). However, the duplicate-row check is flagged as "pending Phase D recomputation," so full deduplication verification against the Parquet backend is not yet confirmed — this should be resolved before treating the dataset as fully validated. Additionally, the "Sample Data" section shows zero rows pending Phase D wiring, meaning no manual spot-check of actual values has been performed yet — a documentation gap worth flagging before downstream use.
3. Key Column Distributions
The core value column (EDCNMIPCMEPS) ranges from $183.94 to $522.92 per capita, with a mean of $389.27 and median of $404.10 — the mean sitting below the median, consistent with the reported negative skew (-0.552), indicating a longer left tail (likely driven by lower expenditure values concentrated in earlier years, e.g., 2000s, before a rise and plateau). The interquartile range (Q1=$319.71, Q3=$472.59) spans roughly $153, indicating that half the observations cluster relatively tightly around the median despite the wide overall range — suggestive of a steady upward trend over time with possible deceleration or plateauing in later years rather than volatile year-to-year swings. With only 22 annual observations, this is a low-N time series better suited for trend/regression analysis than robust statistical outlier detection.
4. Recommended Join Keys
The observationdate column (annual, January 1 each year, 2000–2021) is the natural join key. Since it's annual granularity, cross-dataset correlation requires partner datasets aggregated to the same yearly frequency (or resampled from monthly/quarterly data via mean/sum to year-start dates) to avoid misalignment.
5. Suggested Complementary Datasets
Strong pairing candidates include: (a) other MEPS-basis disease expenditure series from FRED (e.g., circulatory, mental health, musculoskeletal categories) for comparative disease-cost-burden analysis; (b) CDC/NHANES diabetes and obesity prevalence rates; (c) CPI for Medical Care Services (FRED: CPIMEDSL) to distinguish price-inflation effects from utilization growth; (d) health insurance coverage rates (e.g., Census/KFF uninsured rate) to explore access-cost relationships; and (e) pharmaceutical price indices, particularly insulin/diabetes drug pricing, given the strong overlap with metabolic disease spending drivers.
Columns
- observation_date (date)
- EDCNMIPCMEPS (decimal)